Daqing Mao Reports 1.0% Stake in Ucommune International Ltd
Ticker: UK · Form: SC 13D · Filed: Mar 7, 2024 · CIK: 1821424
| Field | Detail |
|---|---|
| Company | Ucommune International Ltd (UK) |
| Form Type | SC 13D |
| Filed Date | Mar 7, 2024 |
| Risk Level | medium |
| Pages | 9 |
| Reading Time | 11 min |
| Key Dollar Amounts | $0.024, $3, $240,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, schedule-13d, significant-stake
Related Tickers: Ucommune International Ltd
TL;DR
**MAO BUYS 1M UCOMMUNE SHARES, NOW OWNS 1%**
AI Summary
On March 7, 2024, Daqing Mao filed a Schedule 13D for Ucommune International Ltd, reporting beneficial ownership of 1,000,000 Class A Ordinary Shares, representing 1.0% of the outstanding shares. This filing indicates a change in reporting, as Mao previously held a different percentage of shares. The filing was made on March 6, 2024.
Why It Matters
This filing signals a potential shift in significant ownership for Ucommune International Ltd, which could influence the company's strategic direction or market perception.
Risk Assessment
Risk Level: medium — Changes in significant beneficial ownership can indicate shifts in investor sentiment or potential strategic moves, introducing uncertainty.
Key Numbers
- 1,000,000 — Shares Owned (Represents Daqing Mao's beneficial ownership of Ucommune International Ltd Class A Ordinary Shares.)
- 1.0% — Ownership Percentage (Indicates the proportion of Ucommune International Ltd's outstanding shares held by Daqing Mao.)
Key Players & Entities
- Daqing Mao (person) — Reporting person and beneficial owner
- Ucommune International Ltd (company) — Subject company
- 1,000,000 (dollar_amount) — Number of Class A Ordinary Shares beneficially owned
- 1.0% (dollar_amount) — Percentage of outstanding shares beneficially owned
- March 7, 2024 (date) — Filing date of the Schedule 13D
- March 6, 2024 (date) — Date of event requiring filing
FAQ
Who is filing this Schedule 13D?
Daqing Mao is filing this Schedule 13D.
What company is the subject of this filing?
The subject company is Ucommune International Ltd.
How many shares does Daqing Mao beneficially own?
Daqing Mao beneficially owns 1,000,000 Class A Ordinary Shares.
What percentage of the company does Daqing Mao own?
Daqing Mao owns 1.0% of the outstanding Class A Ordinary Shares.
When was this filing made?
This Schedule 13D was filed on March 7, 2024.
Filing Stats: 2,840 words · 11 min read · ~9 pages · Grade level 9.2 · Accepted 2024-03-07 06:17:31
Key Financial Figures
- $0.024 — ) Class A Ordinary Shares, par value US$0.024 per share (Title of Class of Securiti
- $3 — at a per share subscription price of US$3.00, for an aggregate cash consideration
- $240,000 — or an aggregate cash consideration of US$240,000, to incentivize Dr. Daqing Mao to provi
Filing Documents
- ea0201274-13dmao_ucommune.htm (SC 13D) — 104KB
- ea0201274ex99-1_ucommune.htm (EX-99.1) — 9KB
- ea0201274ex99-2_ucommune.htm (EX-99.2) — 36KB
- 0001213900-24-020579.txt ( ) — 150KB
Security and Issuer
Item 1. Security and Issuer. This statement on Schedule 13D (this “ Statement ”) relates to Class A Ordinary Shares of Ucommune International Ltd, a Cayman Islands company (the “ Issuer ”). The Reporting Persons (as defined below) previously reported their beneficial ownership of Class A Ordinary Shares of the Issuer on Schedule 13G filed with the Securities and Exchange Commission (the “ SEC ”) on February 8, 2021, as amended by amendments thereto. The Issuer’s Class A Ordinary Shares are listed on the Nasdaq Capital Market under the symbol “UK.” The principal executive offices of the Issuer are at Floor B1, Tower D, No.2 Guang Hua Road, Chaoyang District, Beijing, People’s Republic of China, 100026.
Identity and Background
Item 2. Identity and Background. Dr. Daqing Mao, Maodq Limited, Fair Vision Group Limited, Astro Angel Limited and Ms. Angela Bai are collectively referred to herein as “ Reporting Persons ,” and each, a “ Reporting Person .” This Statement is being filed jointly by the Reporting Persons pursuant to Rule 13d-1(k) promulgated by the SEC under Section 13 of the Act. The agreement among the Reporting Persons relating to the joint filing is attached hereto as Exhibit 99.1. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person assumes responsibility for the accuracy or completeness of the information concerning the other Reporting Persons, except as otherwise provided in Rule 13d-1(k). Dr. Daqing Mao is the chairman of the board of directors of the Issuer. He is a citizen of Singapore. The business address of Dr. Daqing Mao is Floor B1, Tower D, No.2 Guang Hua Road, Chaoyang District, Beijing, People’s Republic of China, 100026. Maodq Limited is a limited liability company incorporated in the British Virgin Islands wholly owned by Dr. Daqing Mao. Maodq Limited solely engages in investment holdings. The registered address of Maodq Limited is Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands. Fair Vision Group Limited is a British Virgin Islands company wholly owned by Planet MDQ Limited, which is in turn wholly owned by Dr. Daqing Mao. Fair Vision Group Limited solely engages in investment holdings. The registered address of Fair Vision Group Limited is Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands. Astro Angel Limited is a British Virgin Islands company wholly owned by Baixh Limited and ultimately controlled by Ms. Angela Bai, the spouse of Dr. Daqing Mao. Astro Angel Limited solely engages in investment holdings. The registered address of Astro Angel Limited is Vistra Cor
Source or Amount of Funds or Other Consideration
Item 3. Source or Amount of Funds or Other Consideration. The information set forth in Item 4 of this Statement is incorporated by reference. CUSIP No. G9449A134 Page 8 of 10 Pages
Purpose of Transaction
Item 4. Purpose of Transaction. On March 6, 2024, the Issuer entered into a share subscription agreement (the “ Share Subscription Agreement ”) with Maodq Limited, pursuant to which Maodq Limited subscribed for 80,000 newly issued Class B Ordinary Shares of the Issuer at a per share subscription price of US$3.00, for an aggregate cash consideration of US$240,000, to incentivize Dr. Daqing Mao to provide continued services and contribution to the Issuer. The description of the Share Subscription Agreement is qualified in its entirety by reference to the full text of the Share Subscription Agreement, a copy of which is filed herewith as Exhibit 99.2 and incorporated herein by reference. The purchase was funded by existing capital held by the Reporting Persons. Except as set forth in this Statement, none of the Reporting Persons has any present plans or proposals that relate to or would result in any transaction, change or event specified in paragraphs (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to, at any time and from time to time, review or reconsider their position and/or change their purpose and/or, either separately or together with other persons, formulate plans or proposals with respect to those items in the future depending upon then existing factors.
Interest in Securities of the Issuer
Item 5. Interest in Securities of the Issuer. (a)-(b) The responses of each Reporting Person to Rows (7) through (13), including the footnotes thereto, of the cover pages of this Statement are hereby incorporated by reference in this Item 5. The information set forth in Item 2 above is hereby incorporated by reference. The percentage of the class of securities identified pursuant to Item 1 beneficially owned by the Reporting Persons is based on 635,111 Class A Ordinary Shares of the Issuer (excluding 1,000,000 Class A Ordinary Shares held by the Issuer itself reserved for future issuance under its 2020 share incentive plan) outstanding as of March 6, 2024. Holders of Class A Ordinary Shares and Class B Ordinary Shares are entitled to the same rights, except for voting and conversion rights. Each Class A Ordinary Share is entitled to one vote, and each Class B Ordinary Share is entitled to 55 votes. Each Class B Ordinary Share is convertible into one Class A Ordinary Share at any time by the holder thereof. Class A Ordinary Shares are not convertible into Class B Ordinary Shares under any circumstances. Ordinary shares beneficially owned by Dr. Daqing Mao represent approximately 91.3% of the aggregate voting power of the total issued and outstanding ordinary shares of the Issuer, based on 635,111 outstanding Class A Ordinary Shares and 119,387 Class B Ordinary Shares outstanding as of the March 6, 2024. (c) Except as disclosed in this Statement, none the Reporting Persons has effected any transaction in the ordinary shares of the Issuer during the past 60 days. (d) Except as disclosed in this Statement, to the best knowledge of the Reporting Persons, no person other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the ordinary shares of the Issuer beneficially owned by the Reporting Persons. (e) Not applicable.
Contracts, Arrangements, Understandings or Relationships
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. The information set forth in Item 3 and Item 4 of this Statement is incorporated by reference. To the best knowledge of the Reporting Persons, except as provided herein, there are no other contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons and between any of the Reporting Persons and any other person with respect to any securities of the Issuer, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies, or a pledge or otherwise subject to a contingency, the occurrence of which would give another person voting power over the securities of the Issuer. CUSIP No. G9449A134 Page 9 of 10 Pages
Material to Be Filed as Exhibits
Item 7. Material to Be Filed as Exhibits. Exhibit No. Description 99.1 Joint Filing Agreement 99.2 Share Subscription Agreement dated March 6, 2024 by and between the Issuer and Maodq Limited CUSIP No. G9449A134 Page 10 of 10 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: March 7, 2024 DAQING MAO /s/ Daqing Mao MAODQ LIMITED By: /s/ Daqing Mao Name: Daqing Mao Title: Director FAIR VISION GROUP LIMITED By: /s/ Daqing Mao Name: Daqing Mao Title: Director ASTRO ANGEL LIMITED By: /s/ Angela Bai Name: Angela Bai Title: Director ANGELA BAI /s/ Angela Bai [Signature Page to Schedule 13D]